Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 12.45
+0.25 (2.05%)
Sep 15, 2026, 2:00 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 76.56 million as of September 15, 2026. Its market cap has decreased by -87.14% in one year.
Market Cap
76.56M
Enterprise Value
-66.07M
Revenue
54.81M
Ranking
n/a
PE Ratio
4.84
Stock Price
12.45
ChartMarket Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has decreased from 393.23M to 76.56M, a decrease of -80.53%. That is a compound annual growth rate of -11.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 76.56M | -87.51% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neith | 793.51M |
| Lukas Biomedical | 766.30M |
| MegaPro Biomedical | 744.29M |
| BioLASCO Taiwan | 735.06M |
| SynCore Biotechnology Co.,Ltd | 662.86M |
| Enimmune | 612.00M |
| TaiwanJ Pharmaceuticals | 563.26M |
| LAUNXP Biomedical | 488.44M |